Ligand Pharmaceuticals Inc
NASDAQ:LGND
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Price:
232.34
USD
8.85%
Market Closed
Market Cap:
$4.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
C
|
Chu Kong Shipping Enterprises Group Co Ltd
XBER:CKW
|
HK |
|
Ovid Therapeutics Inc
NASDAQ:OVID
|
US |
|
L
|
Lysaght Galvanized Steel Bhd
KLSE:LYSAGHT
|
MY |
|
i-mobile Co Ltd
TSE:6535
|
JP |
|
First Real Estate Investment Trust of New Jersey Inc
OTC:FREVS
|
US |
|
W
|
Wha Yu Industrial Co Ltd
TWSE:3419
|
TW |
|
Johnson Health Tech Co Ltd
TWSE:1736
|
TW |
|
T.Hasegawa Co Ltd
TSE:4958
|
JP |
|
K
|
Keep Inc
HKEX:3650
|
CN |
|
G
|
GTM Holdings Corp
TWSE:1437
|
TW |
|
Guanghui Logistics Co Ltd
SSE:600603
|
CN |
|
Clenergy Technology Co Ltd
SSE:603628
|
CN |
|
Soliton Systems KK
TSE:3040
|
JP |
|
C
|
Chuou International Group Co Ltd
TSE:7170
|
JP |
|
AK Medical Holdings Ltd
HKEX:1789
|
CN |
|
S
|
Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
|
CN |
|
H
|
Hektar Real Estate Investment Trust
KLSE:HEKTAR
|
MY |
|
C
|
Clal Insurance Enterprises Holdings Ltd
TASE:CLIS
|
IL |
|
M
|
Marlborough Wine Estates Group Ltd
NZX:MWE
|
NZ |
|
P
|
Pacific Radiance Ltd
SGX:T8V
|
SG |
|
Shanghai STEP Electric Corp
SZSE:002527
|
CN |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
ADTRAN Inc
NASDAQ:ADTN
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Ligand Pharmaceuticals Inc (LGND)
under the Base Case is
hidden
USD.
Compared with the current market price of 232.34 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LGND Multiples-Based Value
LOCKED
Multiples Across Competitors
LGND Competitors Multiples
Ligand Pharmaceuticals Inc Competitors
Ligand Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
4.6B USD | 17.1 | 36.9 | 53.2 | 91.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.7 | 13.2 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.3 | 39.5 | 42.8 | 43.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
